share_log

Organon & Co Shares Are Trading Lower After the FDA Extended the Target Action Date of Its Review for the Company's Supplemental New Drug Application for Vtama Cream.

Benzinga ·  Nov 5 11:45
Organon & Co Shares Are Trading Lower After the FDA Extended the Target Action Date of Its Review for the Company's Supplemental New Drug Application for Vtama Cream.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment